29-Apr-2024
Business Wire (Mon, 29-Apr 7:26 PM ET)
Business Wire (Mon, 29-Apr 6:27 PM ET)
Pomlaw (Mon, 29-Apr 3:59 PM ET)
Business Wire (Mon, 29-Apr 9:10 AM ET)
Globe Newswire (Mon, 29-Apr 7:15 AM ET)
Globe Newswire (Sun, 28-Apr 9:00 PM ET)
Globe Newswire (Sun, 28-Apr 11:15 AM ET)
Globe Newswire (Sat, 27-Apr 2:15 PM ET)
Globe Newswire (Sat, 27-Apr 9:55 AM ET)
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Goodrx Holdings - Class A trades on the NASDAQ stock market under the symbol GDRX.
As of April 29, 2024, GDRX stock price declined to $7.15 with 472,338 million shares trading.
GDRX has a beta of 1.84, meaning it tends to be more sensitive to market movements. GDRX has a correlation of 0.08 to the broad based SPY ETF.
GDRX has a market cap of $2.68 billion. This is considered a Mid Cap stock.
Last quarter Goodrx Holdings - Class A reported $197 million in Revenue and $.08 earnings per share. This beat revenue expectation by $814,000 and exceeded earnings estimates by $.01.
In the last 3 years, GDRX stock traded as high as $48.05 and as low as $3.82.
The top ETF exchange traded funds that GDRX belongs to (by Net Assets): VTI, VB, VXF, VBK, SCHA.
GDRX has outperformed the market in the last year with a price return of +53.1% while the SPY ETF gained +24.2%. GDRX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +10.7% and +9.2%, respectively, while the SPY returned +4.1% and +1.1%, respectively.
GDRX support price is $6.98 and resistance is $7.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GDRX stock will trade within this expected range on the day.